Baeten, Jared M.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 3,256

Use of a vaginal ring containing dapivirine for HIV-1 prevention in women.

Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Matovu Kiweewa, F., Nair, G., Mhlanga, F., et al. (2016) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 772

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

Celum, C., Wald, A., Lingappa, J. R., Magaret, A. S., Wang, R. S., Mugo, N., Mujugira, A., Baeten, J. M., Mullins, J. I., Hughes, J. P., et al. (2010) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHerpesvirus Infections and Treatments

Cited by 524

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Bekker, L.-G., Das, M., Abdool Karim, Q., Ahmed, K., Batting, J., Brumskine, W., Gill, K., Harkoo, I., Jaggernath, M., Kigozi, G., et al. (2024) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 523

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

Segal-Maurer, S., DeJesus, E., Stellbrink, H.-J., Castagna, A., Richmond, G. J., Sinclair, G. I., Siripassorn, K., Ruane, P. J., Berhe, M., Wang, H., et al. (2022) · New England Journal of Medicine

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 331

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.

Ahmed, K., Baeten, J. M., Beksinska, M., Bekker, L.-G., Bukusi, E. A., Donnell, D., Gichangi, P. B., Heller, K. B., Hofmeyr, G. J., Justman, J., et al. (2019) · The Lancet

Reproductive Health and ContraceptionHIV/AIDS Research and Interventions

Cited by 299

Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women

Barnabas, R. V., Brown, E. R., Onono, M. A., Bukusi, E. A., Njoroge, B., Winer, R. L., Galloway, D. A., Pinder, L. F., Donnell, D., Wakhungu, I., et al. (2022) · NEJM Evidence

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 223

Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.

Masese, L., Baeten, J. M., Richardson, B. A., Bukusi, E., John-Stewart, G., Graham, S. M., Shafi, J., Kiarie, J., Overbaugh, J., & McClelland, R. S. (2015) · AIDS

Reproductive tract infections researchHIV/AIDS Research and Interventions

Cited by 70

Daily Oral Tenofovir and Emtricitabine–Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1–Uninfected Men and Women: A Subgroup Analysis of a Randomized Trial

Celum, C., Morrow, R. A., Donnell, D., Hong, T., Hendrix, C. W., Thomas, K. K., Fife, K. H., Nakku-Joloba, E., Mujugira, A., Baeten, J. M., et al. (2014) · Annals of Internal Medicine

Herpesvirus Infections and TreatmentsHIV/AIDS Research and Interventions

Cited by 61

Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials

Stewart, J., Krows, M. L., Schaafsma, T. T., Heller, K. B., Brown, E. R., Boonyaratanakornkit, J., Brown, C. E., Leingang, H., Liou, C., Bershteyn, A., et al. (2022) · JAMA Network Open

Ethics in Clinical ResearchCOVID-19 Clinical Research Studies

Cited by 54

Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial

Irungu, E. M., Mugwanya, K. K., Mugo, N. R., Bukusi, E. A., Donnell, D., Odoyo, J., Wamoni, E., Peacock, S., Morton, J. F., Ngure, K., et al. (2021) · The Lancet Global Health

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 49

Daily Short Message Service Surveys to Measure Sexual Behavior and Pre-exposure Prophylaxis Use Among Kenyan Men and Women

Curran, K., Mugo, N. R., Kurth, A., Ngure, K., Heffron, R., Donnell, D., Celum, C., & Baeten, J. M. (2013) · AIDS and Behavior

HIV/AIDS Research and InterventionsMobile Health and mHealth Applications

Cited by 42

Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya

for the Partners Scale Up Team, Mugwanya, K. K., Irungu, E., Bukusi, E., Mugo, N. R., Odoyo, J., Wamoni, E., Ngure, K., Morton, J. F., Peebles, K., et al. (2018) · Implementation Science

HIV/AIDS Research and InterventionsHealth Policy Implementation Science

Cited by 34

Acquisition of sexually transmitted infections among women using a variety of contraceptive options: a prospective study among high-risk African women.

Kiweewa, F. M., Brown, E., Mishra, A., Nair, G., Palanee‐Phillips, T., Mgodi, N., Nakabiito, C., Chakhtoura, N., Hillier, S. L., Baeten, J. M., et al. (2019) · Journal of the International AIDS Society

Reproductive tract infections researchReproductive Health and Contraception

Cited by 19

Patterns of PrEP continuation and coverage in the first year of use: a latent class analysis of a programmatic PrEP trial in Kenya

Mugwanya, K. K., Palayew, A., Schaafsma, T., Irungu, E. M., Bukusi, E., Mugo, N., Morton, J., Odoyo, J., Ngure, K., Baeten, J. M., et al. (2023) · Journal of the International AIDS Society

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 16